Association Between Intestinal Neoplasms and Celiac Disease: A Review

Overview

Journal World J Gastrointest Oncol

Publisher Baishideng Publishing Group

Date 2021 Oct 7

PMID 34616509

Citations 6

Authors

Man Wang

Ming Yu

Wen-Jie Kong

Mei Cui

Feng Gao

Affiliations

Soon will be listed here.

Abstract

Celiac disease (CD) is a chronic immune-mediated intestinal disease with genetic susceptibility. It is characterized by inflammatory damage to the small intestine after ingestion of cereals and products containing gluten protein. In recent years, the global prevalence rate of CD has been approximately 1%, and is gradually increasing. CD patients adhere to a gluten-free diet (GFD) throughout their entire life. However, it is difficult to adhere strictly to a GFD. Untreated CD may be accompanied by gastrointestinal symptoms, such as diarrhea, abdominal pain, and extraintestinal symptoms caused by secondary malnutrition. Many studies have suggested that CD is associated with intestinal tumors such as enteropathy-associated T-cell lymphoma (EATL), small bowel cancer (SBC), and colorectal cancer. In this study, we reviewed related studies published in the literature to provide a reference for the prevention and treatment of intestinal tumors in patients with CD. Compared with the general population, CD patients had a high total risk of SBC and EATL, but not colorectal cancer. The protective effect of GFD on CD-related malignancies is controversial. Further studies are needed to confirm whether GFD treatment can reduce the risk of intestinal neoplasms in CD.

Citing Articles

Impact of a Gluten-Free Diet in Adults With Celiac Disease: Nutritional Deficiencies and Challenges.

Ghunaim M, Seedi A, Alnuman D, Aljohani S, Aljuhani N, Almourai M Cureus. 2025; 16(12):e74983.

PMID: 39744258 PMC: 11692684. DOI: 10.7759/cureus.74983.

Meta-analysis of postoperative incision infection risk factors in colorectal cancer surgery.

Jia L, Zhao H, Liu J Front Surg. 2024; 11:1415357.

PMID: 39193402 PMC: 11347452. DOI: 10.3389/fsurg.2024.1415357.

Update on the Pathogenesis of Enteropathy-Associated T-Cell Lymphoma.

Abdullah S, Goa P, Vandenberghe E, Flavin R Diagnostics (Basel). 2023; 13(16).

PMID: 37627888 PMC: 10453492. DOI: 10.3390/diagnostics13162629.

Increased Risk of Colorectal Cancer in Patients With Celiac Disease: A Population-Based Study.

Onwuzo S, Boustany A, Saleh M, Gupta R, Onwuzo C, Mascarenhas Monteiro J Cureus. 2023; 15(3):e36964.

PMID: 37009368 PMC: 10065125. DOI: 10.7759/cureus.36964.

Epidemiological, clinical, and histological presentation of celiac disease in Northwest China.

Wang M, Kong W, Feng Y, Lu J, Hui W, Liu W World J Gastroenterol. 2022; 28(12):1272-1283.

PMID: 35431514 PMC: 8968484. DOI: 10.3748/wjg.v28.i12.1272.

References

Daum S, Ullrich R, Heise W, Dederke B, Foss H, Stein H . Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma. J Clin Oncol. 2003; 21(14):2740-6. DOI: 10.1200/JCO.2003.06.026. View

Corrao G, Corazza G, Bagnardi V, Brusco G, Ciacci C, Cottone M . Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001; 358(9279):356-61. DOI: 10.1016/s0140-6736(01)05554-4. View

Spijkerman M, Tan I, Kolkman J, Withoff S, Wijmenga C, Visschedijk M . A large variety of clinical features and concomitant disorders in celiac disease - A cohort study in the Netherlands. Dig Liver Dis. 2016; 48(5):499-505. DOI: 10.1016/j.dld.2016.01.006. View

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders D, Cellier C . European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019; 7(5):583-613. PMC: 6545713. DOI: 10.1177/2050640619844125. View

Catassi C, Bearzi I, Holmes G . Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005; 128(4 Suppl 1):S79-86. DOI: 10.1053/j.gastro.2005.02.027. View

Nijeboer P, van Wanrooij R, van Gils T, Wierdsma N, Tack G, Witte B . Lymphoma development and survival in refractory coeliac disease type II: Histological response as prognostic factor. United European Gastroenterol J. 2017; 5(2):208-217. PMC: 5349358. DOI: 10.1177/2050640616646529. View

Wild D, Robins G, Burley V, Howdle P . Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther. 2010; 32(4):573-81. DOI: 10.1111/j.1365-2036.2010.04386.x. View

Vanoli A, Di Sabatino A, Furlan D, Klersy C, Grillo F, Fiocca R . Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium. J Crohns Colitis. 2017; 11(8):942-953. DOI: 10.1093/ecco-jcc/jjx031. View

Stordal K, Kahrs C, Tapia G, Agardh D, Kurppa K, Stene L . Review article: exposure to microbes and risk of coeliac disease. Aliment Pharmacol Ther. 2020; 53(1):43-62. DOI: 10.1111/apt.16161. View

10.

Freeman H . Adult celiac disease and its malignant complications. Gut Liver. 2010; 3(4):237-46. PMC: 2852736. DOI: 10.5009/gnl.2009.3.4.237. View

11.

Raghav K, Overman M . Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol. 2013; 10(9):534-44. PMC: 6076441. DOI: 10.1038/nrclinonc.2013.132. View

12.

Novakovic B, Novakovic S, Frkovic-Grazio S . A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas. Oncol Rep. 2006; 16(1):191-5. View

13.

Lasa J, Rausch A, Zubiaurre I . Risk of colorectal adenomas in patients with celiac disease: a systematic review and meta-analysis. Rev Gastroenterol Mex (Engl Ed). 2018; 83(2):91-97. DOI: 10.1016/j.rgmx.2017.05.007. View

14.

Husby S, Koletzko S, Korponay-Szabo I, Kurppa K, Mearin M, Ribes-Koninckx C . European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2019; 70(1):141-156. DOI: 10.1097/MPG.0000000000002497. View

15.

Ciccocioppo R, Perfetti V, Corazza G . Treating ETTCL: A matter of early diagnosis and chemotherapy strategies. Dig Liver Dis. 2007; 39(7):642-5. DOI: 10.1016/j.dld.2007.04.009. View

16.

Lindfors K, Ciacci C, Kurppa K, Lundin K, Makharia G, Mearin M . Coeliac disease. Nat Rev Dis Primers. 2019; 5(1):3. DOI: 10.1038/s41572-018-0054-z. View

17.

Thies F, Masson L, Boffetta P, Kris-Etherton P . Oats and bowel disease: a systematic literature review. Br J Nutr. 2014; 112 Suppl 2:S31-43. DOI: 10.1017/S0007114514002293. View

18.

Yokoyama S, Perera P, Waldmann T, Hiroi T, Perera L . Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J Clin Immunol. 2012; 33(3):586-94. PMC: 3594487. DOI: 10.1007/s10875-012-9849-y. View

19.

Brousse N, Meijer J . Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol. 2005; 19(3):401-12. DOI: 10.1016/j.bpg.2005.02.002. View

20.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L . Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet Gastroenterol Hepatol. 2019; 4(12):960-970. DOI: 10.1016/S2468-1253(19)30265-1. View